Literature DB >> 4641791

Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability.

G D Molnar, W F Taylor, M M Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4641791     DOI： 10.1007/bf01218495

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  11 in total

1.  THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.

Authors:  J SCHLICHTKRULL; O MUNCK; M JERSILD
Journal:  Acta Med Scand       Date:  1965-01

2.  QUANTITATIVE ASPECTS OF LABILE DIABETES.

Authors:  G D MOLNAR; C F GASTINEAU; J W ROSEVEAR; K E MOXNESS
Journal:  Diabetes       Date:  1965-05       Impact factor: 9.461

3.  Effects of therapeutic measures in a hyperlabile diabetic.

Authors:  G D MOLNAR; W F MCGUCKIN; J L STRIEBEL; C F GASTINEAU
Journal:  Proc Staff Meet Mayo Clin       Date:  1961-02-01

4.  A clinical comparison of modified insulins.

Authors:  J L IZZO; S L CRUMP; W KUNZ
Journal:  J Clin Invest       Date:  1950-11       Impact factor: 14.808

5.  Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring.

Authors:  G D Molnar; W F Taylor; A L Langworthy
Journal:  Mayo Clin Proc       Date:  1972-10       Impact factor: 7.616

6.  Studies of diabetic instability. II. Tests of insulinogenic reserve with infusions of arginine, glucagon, epinephrine, and saline.

Authors:  G M Cremer; G D Molnar; W F Taylor; K E Moxness; F J Service; L C Gatewood; E Ackerman; J W Rosevear
Journal:  Metabolism       Date:  1971-12       Impact factor: 8.694

7.  Analysis of variance applied to blood glucose values for assessing insulin preparations and state of lability in diabetes.

Authors:  L P Hedner; A Nordén
Journal:  Diabetologia       Date:  1969-04       Impact factor: 10.122

8.  Continuous blood glucose analysis in ambulatory fed subjects. I. General methodology.

Authors:  G D Molnar; E Ackerman; J W Rosevear; L C Gatewood; K E Moxness
Journal:  Mayo Clin Proc       Date:  1968-12       Impact factor: 7.616

9.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

10.  Continuous blood glucose analysis in ambulatory fed subjects. II. Effects of anticoagulation with heparin.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; W F Taylor; G M Cremer; K E Moxness
Journal:  Mayo Clin Proc       Date:  1969-07       Impact factor: 7.616
View more
  69 in total

1.  Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).

Authors:  Renata A Rawlings; Hang Shi; Lo-Hua Yuan; William Brehm; Rodica Pop-Busui; Patrick W Nelson
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

Review 2.  Measures of glycemic variability and links with psychological functioning.

Authors:  Joseph R Rausch
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

3.  Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.

Authors:  Steven J Russell; Mallory A Hillard; Courtney Balliro; Kendra L Magyar; Rajendranath Selagamsetty; Manasi Sinha; Kerry Grennan; Debbie Mondesir; Laya Ekhlaspour; Hui Zheng; Edward R Damiano; Firas H El-Khatib
Journal:  Lancet Diabetes Endocrinol       Date:  2016-02-03       Impact factor: 32.069

4.  Assessment of Glucose Control Metrics by Discriminant Ratio.

Authors:  Vanessa Moscardó; Pau Herrero; Monika Reddy; Nathan R Hill; Pantelis Georgiou; Nick Oliver
Journal:  Diabetes Technol Ther       Date:  2020-10       Impact factor: 6.118

5.  GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data.

Authors:  Dorota Czerwoniuk; Wojciech Fendler; Lukasz Walenciak; Wojciech Mlynarski
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

6.  Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.

Authors:  Firas H El-Khatib; Courtney Balliro; Mallory A Hillard; Kendra L Magyar; Laya Ekhlaspour; Manasi Sinha; Debbie Mondesir; Aryan Esmaeili; Celia Hartigan; Michael J Thompson; Samir Malkani; J Paul Lock; David M Harlan; Paula Clinton; Eliana Frank; Darrell M Wilson; Daniel DeSalvo; Lisa Norlander; Trang Ly; Bruce A Buckingham; Jamie Diner; Milana Dezube; Laura A Young; April Goley; M Sue Kirkman; John B Buse; Hui Zheng; Rajendranath R Selagamsetty; Edward R Damiano; Steven J Russell
Journal:  Lancet       Date:  2016-12-20       Impact factor: 79.321

7.  Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?

Authors:  Louis Monnier; Claude Colette; David R Owens
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Use of a glucose management service improves glycemic control following vascular surgery: an interrupted time-series study.

Authors:  Jessica B Wallaert; Sushela S Chaidarun; Danielle Basta; Kathryn King; Richard Comi; Greg Ogrinc; Brian W Nolan; Philip P Goodney
Journal:  Jt Comm J Qual Patient Saf       Date:  2015-05

9.  Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.

Authors:  I M E Wentholt; W Kulik; R P J Michels; J B L Hoekstra; J H DeVries
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

10.  Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Authors:  Steven J Russell; Firas H El-Khatib; Manasi Sinha; Kendra L Magyar; Katherine McKeon; Laura G Goergen; Courtney Balliro; Mallory A Hillard; David M Nathan; Edward R Damiano
Journal:  N Engl J Med       Date:  2014-06-15       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.